Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Mutual Two-Way Interactions of Curcumin and Gut Microbiota.

Pluta R, Januszewski S, Ułamek-Kozioł M.

Int J Mol Sci. 2020 Feb 5;21(3). pii: E1055. doi: 10.3390/ijms21031055. Review.

2.

Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer's Disease after Ischemia-Reperfusion Brain Injury.

Ułamek-Kozioł M, Czuczwar SJ, Januszewski S, Pluta R.

Int J Mol Sci. 2020 Jan 30;21(3). pii: E892. doi: 10.3390/ijms21030892. Review.

3.

Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia.

Ułamek-Kozioł M, Czuczwar SJ, Januszewski S, Pluta R.

Int J Mol Sci. 2020 Jan 14;21(2). pii: E517. doi: 10.3390/ijms21020517. Review.

4.

Common Proteomic and Genomic Contribution to Ischemic Brain Damage and Alzheimer’s Disease.

Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ.

In: Wisniewski T, editor. Alzheimer’s Disease [Internet]. Brisbane (AU): Codon Publications; 2019 Dec 20. Chapter 4.

5.

To treat or not to treat Alzheimer's disease by the ketogenic diet? That is the question.

Ulamek-Koziol M, Pluta R.

Neural Regen Res. 2020 May;15(5):857-858. doi: 10.4103/1673-5374.268900. No abstract available.

6.

Expression of the Tau Protein and Amyloid Protein Precursor Processing Genes in the CA3 Area of the Hippocampus in the Ischemic Model of Alzheimer's Disease in the Rat.

Pluta R, Ułamek-Kozioł M, Kocki J, Bogucki J, Januszewski S, Bogucka-Kocka A, Czuczwar SJ.

Mol Neurobiol. 2019 Nov 12. doi: 10.1007/s12035-019-01799-z. [Epub ahead of print]

PMID:
31713815
7.

Dysregulation of Autophagy, Mitophagy, and Apoptosis Genes in the CA3 Region of the Hippocampus in the Ischemic Model of Alzheimer's Disease in the Rat.

Ułamek-Kozioł M, Czuczwar SJ, Kocki J, Januszewski S, Bogucki J, Bogucka-Kocka A, Pluta R.

J Alzheimers Dis. 2019;72(4):1279-1286. doi: 10.3233/JAD-190966.

8.

Ketogenic Diet and Epilepsy.

Ułamek-Kozioł M, Czuczwar SJ, Januszewski S, Pluta R.

Nutrients. 2019 Oct 18;11(10). pii: E2510. doi: 10.3390/nu11102510. Review.

9.

Amyloid pathology in the brain after ischemia.

Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar S.

Folia Neuropathol. 2019;57(3):220-226. doi: 10.5114/fn.2019.88450.

10.

Ketogenic Diet in Alzheimer's Disease.

Rusek M, Pluta R, Ułamek-Kozioł M, Czuczwar SJ.

Int J Mol Sci. 2019 Aug 9;20(16). pii: E3892. doi: 10.3390/ijms20163892. Review.

11.

The role of degenerative pathways in the development of irreversible consequences after brain ischemia.

Pluta R, Ułamek-Kozioł M.

Neural Regen Res. 2019 Jun;14(6):982-983. doi: 10.4103/1673-5374.250574. No abstract available.

12.

Lymphocytes, Platelets, Erythrocytes, and Exosomes as Possible Biomarkers for Alzheimer's Disease Clinical Diagnosis.

Pluta R, Ułamek-Kozioł M.

Adv Exp Med Biol. 2019;1118:71-82. doi: 10.1007/978-3-030-05542-4_4. Review.

PMID:
30747418
13.

Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype.

Pluta R, Ułamek-Kozioł M, Czuczwar SJ.

Int J Mol Sci. 2018 Dec 12;19(12). pii: E4002. doi: 10.3390/ijms19124002. Review.

14.

Tau Protein Dysfunction after Brain Ischemia.

Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ.

J Alzheimers Dis. 2018;66(2):429-437. doi: 10.3233/JAD-180772. Review.

15.

Ischemic tau protein gene induction as an additional key factor driving development of Alzheimer's phenotype changes in CA1 area of hippocampus in an ischemic model of Alzheimer's disease.

Pluta R, Bogucka-Kocka A, Ułamek-Kozioł M, Bogucki J, Januszewski S, Kocki J, Czuczwar SJ.

Pharmacol Rep. 2018 Sep;70(5):881-884. doi: 10.1016/j.pharep.2018.03.004. Epub 2018 Mar 16.

PMID:
32002968
16.

Ischemic tau protein gene induction as an additional key factor driving development of Alzheimer's phenotype changes in CA1 area of hippocampus in an ischemic model of Alzheimer's disease.

Pluta R, Bogucka-Kocka A, Ułamek-Kozioł M, Bogucki J, Januszewski S, Kocki J, Czuczwar SJ.

Pharmacol Rep. 2018 Oct;70(5):881-884. doi: 10.1016/j.pharep.2018.03.004. Epub 2018 Mar 16.

PMID:
30096486
17.

Platelets, lymphocytes and erythrocytes from Alzheimer's disease patients: the quest for blood cell-based biomarkers.

Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ.

Folia Neuropathol. 2018;56(1):14-20. doi: 10.5114/fn.2018.74655. Review.

18.

Dysregulation of Alzheimer's disease-related genes and proteins following cardiac arrest.

Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ.

Folia Neuropathol. 2017;55(4):283-288. doi: 10.5114/fn.2017.72384. Review.

19.

Autophagy, mitophagy and apoptotic gene changes in the hippocampal CA1 area in a rat ischemic model of Alzheimer's disease.

Ułamek-Kozioł M, Kocki J, Bogucka-Kocka A, Januszewski S, Bogucki J, Czuczwar SJ, Pluta R.

Pharmacol Rep. 2017 Dec;69(6):1289-1294. doi: 10.1016/j.pharep.2017.07.015. Epub 2017 Jul 14.

PMID:
29128811
20.

To treat or not to treat drug-refractory epilepsy by the ketogenic diet? That is the question.

Ułamek-Kozioł M, Pluta R, Bogucka-Kocka A, Czuczwar SJ.

Ann Agric Environ Med. 2016 Dec 23;23(4):533-536. doi: 10.5604/12321966.1226841. Review.

Supplemental Content

Loading ...
Support Center